Skip to main content
TipRanks
Go Ultimate75% OFF

RedHill Biopharma (RDHL) Q2 2026 Earnings Report

904 Followers

RDHL Q2 2026 EPS Results

Actual EPS
-$1.01
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$2.32

RDHL Q2 2026 Revenue Results

Actual Revenue
$0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-100.00%

Earnings Announcement Details

Quarter
Q2 2026
Date
09/30/2026
Time
After Close
Conference Call
Wednesday, September 30, 2026
RDHL Upcoming Earnings

RedHill Biopharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

RDHL Earnings History

RDHL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 18, 20272026 (Q4)―-―――
Sep 30, 20262026 (Q2)―-1.01-2.3256.56% (+1.31)
Apr 27, 20262025 (Q4)―-――
Sep 05, 20252025 (Q2)―-2.320―
May 13, 20252025 (Q1)―-――
Apr 10, 20252024 (Q4)―-――
Aug 29, 20242024 (Q2)―0.001-100.00% (-1.00)
May 07, 20242024 (Q1)―-――
Apr 08, 20242023 (Q4)―--0.05―
Nov 15, 20232023 (Q3)―0.04-2.4101.67% (+2.44)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed